Healthcare provider profile · identity verified

Leyla M Solis, MD

Family Practice · SAINT FRANCIS, WI · NPI 1659459188

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	810	219
Amlodipine Besylate	Amlodipine Besylate	632	178
Lisinopril	Lisinopril	447	122
Losartan Potassium	Losartan Potassium	391	111
Pantoprazole Sodium	Pantoprazole Sodium	381	91
Levothyroxine Sodium	Levothyroxine Sodium	380	93
Omeprazole	Omeprazole	363	99
Metformin Hcl	Metformin Hcl	310	89
Metoprolol Succinate	Metoprolol Succinate	306	82
Furosemide	Furosemide	265	60
Gabapentin	Gabapentin	261	82
Hydrochlorothiazide	Hydrochlorothiazide	254	76
Albuterol Sulfate Hfa	Albuterol Sulfate	201	74
Metformin Hcl Er	Metformin Hcl	186	55
Metoprolol Tartrate	Metoprolol Tartrate	185	38
Citalopram Hbr	Citalopram Hydrobromide	165	42
Eliquis	Apixaban	161	32
Donepezil Hcl	Donepezil Hcl	154	33
Fluticasone Propionate	Fluticasone Propionate	150	67
Mirtazapine	Mirtazapine	149	43
Glipizide Er	Glipizide	147	43
Rosuvastatin Calcium	Rosuvastatin Calcium	147	41
Escitalopram Oxalate	Escitalopram Oxalate	146	46
Simvastatin	Simvastatin	134	31
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	123	30
Duloxetine Hcl	Duloxetine Hcl	121	26
Pravastatin Sodium	Pravastatin Sodium	118	31
Sertraline Hcl	Sertraline Hcl	112	30
Clopidogrel	Clopidogrel Bisulfate	110	24
Potassium Chloride	Potassium Chloride	108	26
Tamsulosin Hcl	Tamsulosin Hcl	108	30
Trazodone Hcl	Trazodone Hcl	108	33
Allopurinol	Allopurinol	101	24
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	91	27
Montelukast Sodium	Montelukast Sodium	90	25
Carvedilol	Carvedilol	87	21
Ozempic	Semaglutide	82	14
Alendronate Sodium	Alendronate Sodium	79	28
Famotidine	Famotidine	78	22
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	76	32
Linzess	Linaclotide	71	14
Meloxicam	Meloxicam	70	22
Diclofenac Sodium	Diclofenac Sodium	68	21
Tramadol Hcl	Tramadol Hcl	66	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	65	25
Jardiance	Empagliflozin	63	11
Meclizine Hcl	Meclizine Hcl	63	25
Januvia	Sitagliptin Phosphate	62	17
Memantine Hcl	Memantine Hcl	57	suppressed
Nystatin	Nystatin	56	15
Tizanidine Hcl	Tizanidine Hcl	51	27
Topiramate	Topiramate	51	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	49	14
Glimepiride	Glimepiride	49	16
Dicyclomine Hcl	Dicyclomine Hcl	47	suppressed
Hydralazine Hcl	Hydralazine Hcl	42	13
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	42	11
Venlafaxine Hcl Er	Venlafaxine Hcl	42	suppressed
Ammonium Lactate	Ammonium Lactate	40	16
Acyclovir	Acyclovir	38	suppressed
Pregabalin	Pregabalin	38	suppressed
Breo Ellipta	Fluticasone/Vilanterol	37	suppressed
Naproxen	Naproxen	37	15
Triamcinolone Acetonide	Triamcinolone Acetonide	37	25
Trulicity	Dulaglutide	37	suppressed
Lorazepam	Lorazepam	36	19
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	35	suppressed
Enalapril Maleate	Enalapril Maleate	34	suppressed
Prednisone	Prednisone	34	19
Ropinirole Hcl	Ropinirole Hcl	34	suppressed
Ketoconazole	Ketoconazole	33	11
Lidocaine	Lidocaine	33	11
Lovastatin	Lovastatin	33	suppressed
Paroxetine Hcl	Paroxetine Hcl	33	suppressed
Synthroid	Levothyroxine Sodium	33	suppressed
Alprazolam	Alprazolam	30	suppressed
Divalproex Sodium	Divalproex Sodium	30	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	29	11
Ondansetron Odt	Ondansetron	29	17
Finasteride	Finasteride	28	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	28	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	27	suppressed
Midodrine Hcl	Midodrine Hcl	27	suppressed
Baclofen	Baclofen	25	suppressed
Glipizide	Glipizide	25	suppressed
Ibuprofen	Ibuprofen	25	11
Azithromycin	Azithromycin	24	24
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	24	13
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Amoxicillin	Amoxicillin	23	21
Doxazosin Mesylate	Doxazosin Mesylate	23	suppressed
Irbesartan	Irbesartan	23	suppressed
Lansoprazole	Lansoprazole	23	suppressed
Levemir Flexpen	Insulin Detemir	23	suppressed
Myrbetriq	Mirabegron	23	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	23	suppressed
Valsartan	Valsartan	23	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	22	suppressed
Nyamyc	Nystatin	22	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	21	suppressed
Ventolin Hfa	Albuterol Sulfate	21	suppressed
Ezetimibe	Ezetimibe	20	suppressed
Spironolactone	Spironolactone	20	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	20	suppressed
Atenolol	Atenolol	19	suppressed
Bupropion Xl	Bupropion Hcl	19	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	19	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	19	suppressed
Solifenacin Succinate	Solifenacin Succinate	19	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	19	suppressed
Symbicort	Budesonide/Formoterol Fumarate	19	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	19	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	19	suppressed
Bupropion Hcl	Bupropion Hcl	18	suppressed
Humalog Kwikpen U-100	Insulin Lispro	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Cephalexin	Cephalexin	17	16
Xarelto	Rivaroxaban	17	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	16	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	12
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	15	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Clotrimazole	Clotrimazole	14	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	13	suppressed
Calcitriol	Calcitriol	13	suppressed
Clonidine	Clonidine	13	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	12
Janumet Xr	Sitagliptin Phos/Metformin Hcl	13	suppressed
Latanoprost	Latanoprost	13	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Metolazone	Metolazone	13	suppressed
Silodosin	Silodosin	13	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Humalog Kwikpen U-200	Insulin Lispro	12	suppressed
Mesalamine	Mesalamine	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Bumetanide	Bumetanide	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Torsemide	Torsemide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error